Study Finds Mass Shooters May Be Suffering from Untreated Mental Illnesses

A study recently published in the “Journal of Clinical Psychopharmacology” has found that some domestic mass shooters in the United States suffer from psychiatric disorders that they haven’t been treated for or received medication for. The report, written by Ira D. Glick and colleagues, highlighted that while most individuals who are mentally ill aren’t violent and most who are violent aren’t mentally ill, their research would be useful to lawyers, mental health providers and the public, who needed to be aware of the fact that some unmedicated individuals pose a higher risk of violence.

For their study, the researchers identified 115 individuals who had committed a mass shooting in the country between 1982 and 2019. This information was obtained from the Mother Jones database. However, the researchers did not include shootings associated with conventionally motivated crimes such as gang violence and armed robbery.

In their report, the researchers stated that the assailants died either shortly after or during the crime in most of the incidents. So instead, they centered on 35 cases where the perpetrator survived and went through criminal proceedings, as this offered them information on their psychiatric state and any symptoms of mental illnesses.

The researchers interviewed psychologists and forensic psychiatrists who had cross-examined the perpetrators after they had committed the crime and also analyzed the records for every mass shooting event. Apart from this, they also obtained information from videotaped interviews, public records, court proceedings and social media writings or posts by the offender.

Glick stated that the research found that of the 35 assailants, 32 had signs and symptoms of brain illness that fit the diagnostic criteria for clinical psychiatric disorders. Additionally, 10 of the shooters had been diagnosed with substance-related disorders, personality disorders, delusional disorder and bipolar disorder while another 18 had schizophrenia. In the remaining 7 cases, 4 received no psychiatric diagnosis while the other trio didn’t provide enough information for a diagnosis to be made.

The researchers note that of the 28 offenders who had received a psychiatric diagnosis, none had received treatment or been provided with medication to manage their disorder prior to committing the crime. In addition to this, the researchers found that of the 20 shooters who died at the scene, 8 had been diagnosed with schizophrenia, 7 had been diagnosed with other disorders while the remaining 5 had unknown diagnoses. Likewise, none of them had received proper medication.

Other co-authors of the study include capital defense attorney Michael Laurence, Stanford’s Danielle Kamis and Nina E. Cerfolio, from Mount Sinai Hospital’s Icahn School of Medicine.

The challenge of psychiatric conditions that remain untreated or are inadequately treated is being evaluated by companies such as Cybin Inc. (NEO: CYBN) (OTCQB: CLXPF), which would like to revolutionize mental health care as we know it.

NOTE TO INVESTORS: The latest news and updates relating to Cybin Inc. (NEO: CYBN) (OTCQB: CLXPF) are available in the company’s newsroom at https://ibn.fm/CYBN

About BioMedWire

BioMedWire (BMW) is a bio-med news and content distribution company that provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with BMW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled visibility, recognition and brand awareness. BMW is where news, content and information converge.

To receive SMS text alerts from BioMedWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)

For more information, please visit https://www.BioMedWire.com

Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: http://BMW.fm/Disclaimer

BioMedWire (BMW)
San Francisco, California
www.BioMedWire.com
415.949.5050 Office
Editor@BioMedWire.com

BioMedWire is part of the InvestorBrandNetwork.

Archives

Select A Month

BioMedWire Currently Accepts

Bitcoin

Bitcoin

Bitcoin Cash

Bitcoin Cash

Ethereum

Ethereum

Litecoin

Litecoin

USD Coin

USD Coin

Contact us: 415.949.5050